TRIM inhibitors are a class of chemical compounds designed to target and inhibit the function of the TRIM (Tripartite Motif) family of proteins, which are involved in a variety of cellular processes, including protein ubiquitination, intracellular signaling, and the regulation of gene expression. TRIM proteins are characterized by the presence of a tripartite motif, which includes a RING domain, a B-box, and a coiled-coil region. These proteins play essential roles in regulating the stability and activity of other proteins by tagging them with ubiquitin, marking them for degradation via the proteasome, or modulating their activity in different signaling pathways. By inhibiting TRIM proteins, these compounds can disrupt their ability to regulate ubiquitination and the associated cellular processes, leading to changes in protein homeostasis, signal transduction, and gene regulation.
The development of TRIM inhibitors focuses on identifying small molecules that can specifically bind to key functional domains of TRIM proteins, particularly the RING domain, which is responsible for their E3 ubiquitin ligase activity. These inhibitors work by blocking the ability of TRIM proteins to catalyze the transfer of ubiquitin to target proteins, thereby affecting processes such as protein degradation, signal transduction, and cellular stress responses. Structural studies of various TRIM proteins have provided detailed insights into the molecular architecture of the tripartite motif, guiding the design of inhibitors with high specificity and selectivity. By studying TRIM inhibitors, researchers can gain a deeper understanding of how TRIM proteins regulate critical cellular functions, offering insights into the molecular mechanisms that govern protein turnover, intracellular signaling, and the dynamic control of gene expression. These inhibitors are valuable tools for investigating the diverse roles of the TRIM family in maintaining cellular homeostasis and responding to environmental or intracellular stress.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 targets BET bromodomains, which may indirectly affect TRIM protein-related pathways by altering the transcription of key genes. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor which can increase the cellular concentration of TRIM proteins, potentially affecting their activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, potentially modulating pathways that could interact with TRIM protein function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor which may influence TRIM protein-related signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK and can modulate stress response pathways that TRIM proteins may be part of. | ||||||
BAY 11-7085 | 196309-76-9 | sc-202490 sc-202490A | 10 mg 50 mg | $124.00 $526.00 | 55 | |
This molecule inhibits the degradation of IκBα, affecting NF-κB pathway activation where TRIM proteins may be involved. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which may impact TRIM protein-related pathways by altering cell growth and metabolism. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is another proteasome inhibitor which could affect the stability and function of TRIM proteins. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that could intersect with signaling pathways involving TRIM proteins. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide affects protein degradation, potentially impacting the function of TRIM proteins by modulating related ubiquitin ligase activity. | ||||||